A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...

This significant milestone comes as a part of Bayer’s continuous efforts to raise awareness about the importance of ...

Dr Mohamed Galal, Vice President of Bayer and Executive Director for the Middle East and Pakistan, announced that the company ...

Ahram's Pharmaceutical Conference, which began Saturday under the patronage of Prime Minister Mostafa Madbouly, discussed the ...

By Gina Kolata Millions of Americans take aspirin to prevent a first heart attack or stroke ... Procardia by Pfizer Inc. and as Adalat by the Bayer company.

A trio of recent trials, however, failed to show that direct oral anticoagulants (DOACs) are superior to aspirin for prevention ... and valvular heart disease. "The main thinking of this paper ...

Taking aspirin regularly cuts the risk of developing pancreatic cancer by 40% in people with diabetes and by 20% in the ...

Per the release, severe COVID-19 was a “coronary artery disease risk equivalent,” increasing the risk for heart attack, ...

Taking aspirin regularly cuts the risk of developing pancreatic cancer by a fifth, according to research.The Planets cancer ...

Low-dose aspirin was also recommended to older adults in order to prevent heart disease. But a few years ago, experts stopped recommending it due to its potential side effects. However ...

Recognizing this point should cause us to resist drawing conclusions regarding aspirin use in patients with heart failure - even those with concomitant coronary artery disease - from data ...